TERT and cancer: Thus far, although non-coding mutations are more numerous than coding mutations, very few recurrent cis-regulatory mutations have been found, and recent pan-cancer analyses concluded that in fact only one potential cis-regulatory mutation, in the TERT promoter is highly recurrent [2,3].